HCA Healthcare (HCA) income statement
NYSE · Healthcare · Medical - Care Facilities · 320,000 employees · CEO Samuel N. Hazen
- Price
- $473.19 -1.02%
- Market cap
- $102B
- Enterprise value
- $154B
- Last report
- Q3 '26 filed 2026-10-29
- Next report
- 2027-01-26 EPS est. $8.15
HCA Healthcare (HCA) reported revenue of $19.8B for Q3 '26 (+3.6% year on year), operating income of $2.96B (14.9% of revenue) and net income of $1.58B. Over the last four quarters revenue was $78.7B.
Income statement
| Income statement | Trend | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $17.3B | $17.3B | $17.5B | $17.5B | $18.3B | $18.3B | $18.6B | $19.2B | $19.5B | $19.1B | $20.2B | $19.8B | |
| Cost of revenue | $2.58B | $2.67B | $10.3B | $10.5B | $10.7B | $10.8B | $11B | $11.1B | $11.3B | $16.2B | $17.2B | $16.9B | |
| Gross profit | $14.7B | $14.7B | $7.17B | $6.97B | $7.58B | $7.56B | $7.62B | $8.02B | $8.18B | $2.86B | $3.07B | $2.96B | |
| General & administrative | $7.57B | $7.71B | $7.69B | $7.86B | $7.92B | $8B | $7.86B | $0 | $0 | $0 | $0 | $7.86B | |
| Other operating expenses | $4.35B | $4.4B | -$3.24B | -$3.3B | -$3.19B | -$3.29B | -$3.21B | $5.05B | $5B | -$8.28B | -$8.29B | -$7.86B | |
| Operating expenses | $11.9B | $12.1B | $4.44B | $4.56B | $4.73B | $4.71B | $4.66B | $5.05B | $5B | $0 | $0 | $0 | |
| Operating income | $2.8B | $2.56B | $2.73B | $2.41B | $2.85B | $2.86B | $2.97B | $2.97B | $3.18B | $2.86B | $3.07B | $2.96B | |
| Interest expense | $491M | $512M | $506M | $515M | $528M | $547M | $568M | $561M | $572M | $584M | $599M | $607M | |
| Other non-operating income (gains on investments, FX ...) | -$35M | -$199M | -$12M | -$11M | $185M | -$19M | -$16M | -$14M | -$66M | -$8M | $0 | -$13M | |
| Total non-operating income | -$456M | -$313M | -$494M | -$504M | -$713M | -$528M | -$552M | -$547M | -$506M | -$576M | -$573M | -$594M | |
| Income before tax | $2.35B | $2.25B | $2.24B | $1.91B | $2.13B | $2.33B | $2.42B | $2.42B | $2.67B | $2.29B | $2.49B | $2.37B | |
| Income tax | $484M | $445M | $550M | $424M | $447M | $502M | $524M | $515M | $509M | $430M | $564M | $521M | |
| Net income | $1.61B | $1.59B | $1.46B | $1.27B | $1.44B | $1.61B | $1.65B | $1.64B | $1.88B | $1.62B | $1.7B | $1.58B | |
| EPS (basic) | $6.05 | $6.04 | $5.60 | $4.94 | $5.70 | $6.52 | $6.91 | $7.05 | $8.14 | $7.15 | $7.62 | -$14.67 | |
| EPS (diluted) | $5.93 | $5.94 | $5.53 | $4.89 | $5.63 | $6.45 | $6.83 | $6.96 | $8.14 | $7.15 | $7.62 | $7.27 | |
| Shares (basic, weighted) | 266M | 263M | 263M | 260M | 252M | 249M | 242M | 242M | 231M | 227M | 223M | 222M | |
| Shares (diluted, weighted) | 271M | 268M | 264M | 260M | 255M | 249M | 242M | 242M | 231M | 227M | 223M | 217M | |
| Depreciation & amortization | $789M | $795M | $819M | $842M | $856M | $860M | $863M | $889M | $911M | $930M | $944M | $954M | |
| EBITDA | $3.63B | $3.55B | $3.56B | $3.26B | $3.52B | $3.73B | $3.85B | $3.87B | $4.16B | $3.8B | $4.01B | $3.93B |
| Income statement | Trend | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $41.5B | $43.6B | $46.7B | $51.3B | $51.5B | $58.8B | $60.2B | $65B | $70.6B | $75.6B | |
| Cost of revenue | $6.93B | $7.32B | $7.72B | $8.48B | $8.37B | $36.3B | $37.1B | $39.4B | $41.9B | $44.2B | |
| Gross profit | $34.6B | $36.3B | $39B | $42.9B | $43.2B | $22.5B | $23.2B | $25.6B | $28.7B | $31.4B | |
| General & administrative | $18.9B | $20.1B | $21.4B | $23.6B | $23.9B | $26.8B | $27.7B | $29.5B | $31.2B | $8B | |
| Other operating expenses | $9.46B | $10.2B | $10.9B | $12.1B | $12B | -$14B | -$13.6B | -$13.5B | -$13B | $11.4B | |
| Operating expenses | $28.4B | $30.2B | $32.3B | $35.6B | $35.9B | $12.8B | $14.1B | $16B | $18.1B | $19.4B | |
| Operating income | $6.2B | $6.06B | $6.64B | $7.22B | $7.26B | $9.68B | $9.05B | $9.63B | $10.5B | $12B | |
| Interest expense | $1.6B | $1.67B | $1.77B | $1.84B | $1.56B | $1.53B | $1.74B | $1.94B | $2.06B | $2.25B | |
| Other non-operating income (gains on investments, FX ...) | -$319M | -$14M | -$448M | $150M | $248M | -$1.72B | -$1.27B | -$17M | -$37M | -$115M | |
| Total non-operating income | -$1.39B | -$1.68B | -$1.31B | -$1.97B | -$1.83B | $155M | -$473M | -$1.92B | -$2.02B | -$2.13B | |
| Income before tax | $4.81B | $4.38B | $5.34B | $5.24B | $5.43B | $9.83B | $8.58B | $7.71B | $8.52B | $9.83B | |
| Income tax | $1.38B | $1.64B | $946M | $1.1B | $1.04B | $2.11B | $1.75B | $1.62B | $1.87B | $2.05B | |
| Net income | $2.89B | $2.22B | $3.79B | $3.51B | $3.75B | $6.96B | $5.64B | $5.24B | $5.76B | $6.78B | |
| EPS (basic) | $7.80 | $6.33 | $11.04 | $10.27 | $11.08 | $21.51 | $19.44 | $19.24 | $22.27 | $28.62 | |
| EPS (diluted) | $7.30 | $5.95 | $10.66 | $10.07 | $10.93 | $21.16 | $19.15 | $18.96 | $22.00 | $28.38 | |
| Shares (basic, weighted) | 371M | 350M | 343M | 341M | 339M | 323M | 290M | 272M | 259M | 231M | |
| Shares (diluted, weighted) | 396M | 372M | 355M | 348M | 345M | 329M | 295M | 276M | 262M | 231M | |
| Depreciation & amortization | $1.97B | $2.13B | $2.28B | $2.6B | $2.72B | $2.85B | $2.97B | $3.08B | $3.31B | $3.52B | |
| EBITDA | $8.48B | $8.2B | $9.37B | $9.66B | $9.74B | $14.3B | $13.3B | $12.7B | $13.9B | $15.6B |
Standardised by Financial Modeling Prep from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.
Revenue, operating income and growth
quarterlyMargins
quarterlyCosts as % of revenue
quarterlyThe other statements
Sources
Statements, segment revenue, metrics, estimates: Financial Modeling Prep. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-09-30, 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30
Data as of 2026-11-01